Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 21 | |
|---|---|---|---|---|---|
| Sales | 1,173.81 | 999.17 | 1,036.56 | 1,086.66 | 967.39 |
| Operating profit | 360.25 | 290.41 | 288.28 | 327.79 | 324.71 |
| Interest | 0.80 | 0.27 | 0.19 | 27.78 | 42.83 |
| Gross profit | 366.67 | 309.65 | 296.72 | 306.08 | 282.60 |
| EPS (Rs) | 20.75 | 17.60 | 16.54 | 17.64 | 202.09 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 21 | |
|---|---|---|---|---|---|
| Other income | 7.22 | 19.51 | 8.63 | 6.08 | 0.71 |
| Stock adjustment | -46.50 | -60.58 | 12.39 | 28.94 | -33.69 |
| Raw material | 567.62 | 529.46 | 499.91 | 501.66 | 469.78 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 114.85 | 87.83 | 83.21 | 85.51 | 75.13 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 177.60 | 152.06 | 152.77 | 142.77 | 131.47 |
| Provisions made | - | - | - | - | - |
| Depreciation | 25.74 | 19.81 | 19.29 | 18.58 | 16.79 |
| Taxation | 86.74 | 74.23 | 74.82 | 71.39 | 67.77 |
| Net profit / loss | 254.19 | 215.61 | 202.61 | 216.11 | 198.05 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 24.51 | 24.51 | 24.51 | 24.51 | 1.96 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 30.69 | 29.06 | 27.81 | 30.16 | 33.57 |
| GPM (%) | 31.05 | 30.40 | 28.39 | 28.01 | 29.19 |
| NPM (%) | 21.52 | 21.17 | 19.39 | 19.78 | 20.46 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis